1. Home
  2. ACU vs CYBN Comparison

ACU vs CYBN Comparison

Compare ACU & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACU
  • CYBN
  • Stock Information
  • Founded
  • ACU 1867
  • CYBN 2019
  • Country
  • ACU United States
  • CYBN Canada
  • Employees
  • ACU N/A
  • CYBN N/A
  • Industry
  • ACU Industrial Machinery/Components
  • CYBN Pharmaceuticals and Biotechnology
  • Sector
  • ACU Consumer Discretionary
  • CYBN Health Care
  • Exchange
  • ACU Nasdaq
  • CYBN Nasdaq
  • Market Cap
  • ACU 167.6M
  • CYBN 177.9M
  • IPO Year
  • ACU N/A
  • CYBN N/A
  • Fundamental
  • Price
  • ACU $37.20
  • CYBN $9.13
  • Analyst Decision
  • ACU
  • CYBN Strong Buy
  • Analyst Count
  • ACU 0
  • CYBN 3
  • Target Price
  • ACU N/A
  • CYBN $138.00
  • AVG Volume (30 Days)
  • ACU 8.7K
  • CYBN 213.0K
  • Earning Date
  • ACU 02-28-2025
  • CYBN 02-12-2025
  • Dividend Yield
  • ACU 1.61%
  • CYBN N/A
  • EPS Growth
  • ACU 188.89
  • CYBN N/A
  • EPS
  • ACU 4.84
  • CYBN N/A
  • Revenue
  • ACU $190,488,947.00
  • CYBN N/A
  • Revenue This Year
  • ACU $0.61
  • CYBN N/A
  • Revenue Next Year
  • ACU $4.86
  • CYBN N/A
  • P/E Ratio
  • ACU $7.68
  • CYBN N/A
  • Revenue Growth
  • ACU N/A
  • CYBN N/A
  • 52 Week Low
  • ACU $32.85
  • CYBN $6.50
  • 52 Week High
  • ACU $50.99
  • CYBN $19.84
  • Technical
  • Relative Strength Index (RSI)
  • ACU 46.30
  • CYBN 45.18
  • Support Level
  • ACU $34.35
  • CYBN $8.83
  • Resistance Level
  • ACU $37.32
  • CYBN $9.41
  • Average True Range (ATR)
  • ACU 1.00
  • CYBN 0.59
  • MACD
  • ACU 0.24
  • CYBN -0.02
  • Stochastic Oscillator
  • ACU 88.51
  • CYBN 31.74

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.

Share on Social Networks: